Literature DB >> 20231848

Comparison of changes in mRNA expression of spinal glutamate transporters following induction of two neuropathic pain models.

V Mirzaei1, H Manaheji, N Maghsoudi, J Zaringhalam.   

Abstract

OBJECTIVES: It is now suspected that different kinds of neuropathic pain syndromes may have significantly different mechanisms. To date, much effort has been made to investigate the function of glutamate transporters (GTs) after nerve injury. The aim of this study is to compare the changes in GTs' mRNA expression levels between two distinct models of peripheral neuropathic pain: chronic constriction nerve injury (CCI) and spared nerve injury (SNI).
METHODS: Experiments were performed on animal models of mononeuropathy. Several groups of rats were subjected to behavioral experiments before and 4, 7, and 14 days after the induction of mononeuropathy following the CCI and SNI. Allodynia was assessed by Von Frey filaments, and thermal hyperalgesia was assessed by the paw withdrawal tests. To study molecular experiments, the mRNA expression of (GTs) in CCI and SNI rats, reverse transcription polymerase chain reaction (RT-PCR) were used on days 4 and 14. RESULTS AND
CONCLUSION: The maximum responses of mechanical allodynia and heat hyperalgesia in two distinct neuropathic pain models were detected on day 14. CCI and SNI induced upregulation of three GTs on day 4, which were followed by GTs downregulation in CCI and downregulation of glutamate aspartate transporter (GLAST) and glutamate transporter (GLT)1 in SNI when examined on day 14. These results indicate that there is an inverse correlation between pain responses and expression of GTs, and also changes in expression of spinal GTs may have a critical function in both the induction and maintenance of neuropathic pain in independent peripheral neuropathic pain models.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231848     DOI: 10.1038/sc.2010.21

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  7 in total

1.  The Glt1 glutamate receptor mediates the establishment and perpetuation of chronic visceral pain in an animal model of stress-induced bladder hyperalgesia.

Authors:  A Lenore Ackerman; Forrest C Jellison; Una J Lee; Sylvie Bradesi; Larissa V Rodríguez
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-23

2.  Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1.

Authors:  Julie V Berger; Ronald Deumens; Stéphanie Goursaud; Sabrina Schäfer; Patricia Lavand'homme; Elbert A Joosten; Emmanuel Hermans
Journal:  J Neuroinflammation       Date:  2011-04-13       Impact factor: 8.322

3.  Minocycline potentiates the anti-hyperalgesic effect of ceftriaxone in CCI-induced neuropathic pain in rats.

Authors:  B Amin; V Hajhashemi; H Hosseinzadeh
Journal:  Res Pharm Sci       Date:  2015 Jan-Feb

4.  Evaluation of the antinociceptive activities of enaminone compounds on the formalin and hot plate tests in mice.

Authors:  Willias Masocha; Samuel B Kombian; Ivan O Edafiogho
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

5.  Altered glial glutamate transporter expression in descending circuitry and the emergence of pain chronicity.

Authors:  Wei Guo; Satoshi Imai; Shiping Zou; Jiale Yang; Mineo Watanabe; Jing Wang; Ronald Dubner; Feng Wei; Ke Ren
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.370

6.  Induction of spinal long-term synaptic potentiation is sensitive to inhibition of neuronal NOS in L5 spinal nerve-transected rats.

Authors:  Zahra Bahari; Homa Manaheji; Narges Hosseinmardi; Gholam Hossein Meftahi; Mehdi Sadeghi; Samira Danialy; Seyed Mohammad Noorbakhsh
Journal:  EXCLI J       Date:  2014-07-14       Impact factor: 4.068

7.  Extracellular microvesicles from astrocytes contain functional glutamate transporters: regulation by protein kinase C and cell activation.

Authors:  Romain-Daniel Gosselin; Patrick Meylan; Isabelle Decosterd
Journal:  Front Cell Neurosci       Date:  2013-12-10       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.